PhD, MACP, RP
Dr. Sakina Rizvi received her PhD in the Faculty of Pharmacy and Collaborative Program in Neuroscience at the University of Toronto. She has over 10 years of research experience in psychiatry across the areas of neuroimaging, neuropsychology, psychotherapy, pharmacology, and scale development; with a focus in Major Depressive Disorder. Currently, Dr. Rizvi is a Scientist in the Arthur Sommer Rotenberg (ASR) Suicide and Depression Studies Program at St. Michael’s Hospital and Associate Professor in the Department of Psychiatry, University of Toronto. She is also a Registered Psychotherapist with the College of Registered Psychotherapists of Ontario. Her research within the ASR program aims to characterize the neurobiology of suicide risk and treatment resistant depression, primarily through the use of fMRI and PET neuroimaging, and to develop and test novel psychotherapeutic strategies. Within her biomarker research, she is evaluating brain reward mechanisms as predictors of treatment outcome and as a path for intervention. In addition to her research, Dr. Rizvi is actively involved in outreach and advocacy projects with an emphasis on providing mental health education to the community through the creative arts.